A significant percentage (45 %), of the tumors included in this study was from patients with a family history of breast cancer (the Swedish average is 35 %) with BRCA1 and BRCA12 accounting for 8 % and 3 %, respectively [47]. The gene discussed is BRCA1; the disease is breast carcinoma.